title: Bio-ecological control of perioperative and ITU morbidity.
abstract: BACKGROUND
  Perioperative and intensive therapy unit (ITU) morbidity and mortality has remained unchanged during the past several decades, and this at an unacceptably high level. It is most likely, in the EU countries annually, that more than 1 million people suffer severe sepsis and some 300,000 die. Pharmaceutical attempts at prevention and treatment have, despite extensive efforts, hitherto failed to improve outcome more significantly. Much supports the fact that sepsis and its severe consequences are results of a malfunctioning innate immune system, impaired by both lifestyle and disease. A series of mostly simple measures to prevent further deterioration of the immune system, and to boost it, is recommended. Among the measures recommended are some modifications of surgical and postoperative management: restricted use of antibiotics, attempts made to maintain salivation and GI secretions, omission of prophylactic gastric decompression, postoperative drainage and preoperative bowel preparation, restricted use of stored blood, avoidance of overload with nutrients, uninterrupted enteral nutrition but also tight blood glucose control, supply of antioxidants, administration of prebiotic fibre and probiotic lactic acid bacteria. Nutritional control of postoperative morbidity includes use of so-called synbiotics, e.g. a combination of bioactive lactic acid bacteria (LAB) and bioactive plant fibres.
  
  
  RESULTS
  Dramatic reduction in (in reality, almost abolishment of) septic morbidity is reported following supplementation of specific bioactive lactic bacteria in combination with prebiotic plant fibres, as tried in controlled studies in connection with extensive abdominal operations, liver transplantation and severe acute pancreatitis.
authors: Departments of Hepatology and Surgery, University College, London Medical School, 69-75 Chenies Mews, London WC1E 6HX, UK. s.bengmark@ucl.ac.uk
authors: Stig
authors: S
authors: Bengmark
mesh_terms: D003422:Critical Care / Q000379:methods*; D006801:Humans; D007107:Immune System / Q000503:physiopathology*; D007362:Intensive Care Units; D018529:Nutritional Support / Q000379:methods; D019936:Probiotics / Q000627:therapeutic use; D018805:Sepsis / Q000503:physiopathology / Q000628:therapy*; D013514:Surgical Procedures, Operative / Q000379:methods*